Ming Liu Selected Research

Brefeldin A

1/2022	Brefeldin A Induces Apoptosis, Inhibits BCR-ABL Activation, and Triggers BCRABL Degradation in Chronic Myeloid Leukemia K562 Cells.
10/2021	Brefeldin A delivery nanomicelles in hepatocellular carcinoma therapy: Characterization, cytotoxic evaluation in vitro, and antitumor efficiency in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming Liu Research Topics

Disease

330	Neoplasms (Cancer) 12/2022 - 08/2002
67	Stroke (Strokes) 07/2022 - 04/2008
66	Ischemic Stroke 04/2022 - 06/2007
46	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2003
45	Infections 01/2022 - 12/2006
42	Inflammation (Inflammations) 10/2022 - 01/2010
39	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 05/2009
35	Type 2 Diabetes Mellitus (MODY) 06/2022 - 09/2009
31	Carcinogenesis 02/2022 - 07/2005
31	Carcinoma (Carcinomatosis) 01/2022 - 01/2003
28	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2007
27	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 09/2005
26	Pain (Aches) 03/2022 - 12/2010
26	Lung Neoplasms (Lung Cancer) 02/2022 - 06/2004
24	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2003
22	Hemorrhage 04/2022 - 04/2009
22	Hypertension (High Blood Pressure) 03/2022 - 01/2011
22	Cerebral Hemorrhage 03/2022 - 11/2010
21	Stomach Neoplasms (Stomach Cancer) 09/2021 - 03/2008
21	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2007
19	Obesity 04/2022 - 07/2014
19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 07/2005
17	Atherosclerosis 01/2022 - 12/2002
16	Hypoxia (Hypoxemia) 01/2022 - 11/2010
15	Diabetes Mellitus 10/2022 - 04/2005
15	Pneumonia (Pneumonitis) 01/2021 - 09/2006
14	Body Weight (Weight, Body) 12/2021 - 12/2007
14	Laryngeal Neoplasms (Laryngeal Cancer) 01/2020 - 01/2008
13	Atrial Fibrillation 01/2022 - 05/2015
12	Fibrosis (Cirrhosis) 07/2022 - 05/2011
12	Thrombosis (Thrombus) 05/2022 - 01/2004
12	Insulin Resistance 04/2022 - 12/2007
12	Heart Failure 01/2022 - 11/2008
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2015
12	Adenocarcinoma of Lung 01/2021 - 11/2010
12	Lymphatic Metastasis 01/2021 - 01/2003
11	Hematoma 07/2022 - 08/2014
11	Hyperglycemia 05/2022 - 12/2007
10	COVID-19 05/2022 - 07/2020
10	Rheumatic Heart Disease (Rheumatic Heart Diseases) 01/2021 - 01/2016
10	Pre-Eclampsia (Preeclampsia) 01/2019 - 08/2012
9	Adenocarcinoma 01/2022 - 07/2011
9	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 04/2008
9	Colonic Neoplasms (Colon Cancer) 01/2020 - 04/2004
8	Infarction (Infarctions) 04/2022 - 01/2011
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 04/2008
8	Virus Diseases (Viral Diseases) 01/2022 - 01/2012
8	Myocardial Infarction 01/2021 - 04/2009
8	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

104	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2003
74	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2011
49	Pharmaceutical PreparationsIBA 08/2022 - 08/2003
43	MicroRNAs (MicroRNA)IBA 11/2022 - 12/2010
35	Biological ProductsIBA 06/2022 - 01/2003
30	RNA (Ribonucleic Acid)IBA 11/2022 - 06/2010
29	CytokinesIBA 02/2022 - 12/2002
25	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2003
24	Long Noncoding RNAIBA 01/2022 - 01/2013
23	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 12/2007
22	Messenger RNA (mRNA)IBA 11/2022 - 09/2009
19	LipidsIBA 06/2022 - 04/2008
18	Insulin (Novolin)FDA Link 06/2022 - 12/2006
17	Small Interfering RNA (siRNA)IBA 01/2022 - 08/2008
15	Immune Checkpoint InhibitorsIBA 01/2022 - 09/2018
15	VaccinesIBA 12/2020 - 02/2003
14	Peptides (Polypeptides)IBA 05/2022 - 03/2012
14	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2013
14	ProinsulinIBA 09/2021 - 04/2005
13	AntigensIBA 12/2021 - 04/2006
12	Phosphotransferases (Kinase)IBA 02/2022 - 06/2012
12	Indicators and Reagents (Reagents)IBA 01/2021 - 08/2006
11	LipopolysaccharidesIBA 04/2022 - 03/2008
11	Monoclonal AntibodiesIBA 02/2022 - 03/2009
11	AlbuminsIBA 01/2022 - 01/2012
11	LigandsIBA 11/2021 - 11/2007
11	CreatinineIBA 01/2021 - 12/2008
10	EnzymesIBA 01/2022 - 12/2006
10	Therapeutic UsesIBA 01/2022 - 05/2003
10	Circular RNAIBA 01/2021 - 01/2016
9	CalciumIBA 04/2022 - 05/2012
9	Hemoglobins (Hemoglobin)IBA 03/2022 - 01/2013
9	oxidized low density lipoproteinIBA 01/2022 - 12/2002
9	CateninsIBA 12/2021 - 11/2013
9	Matrix Metalloproteinases (MMPs)IBA 10/2021 - 12/2002
9	Oxygen (Dioxygen)IBA 01/2021 - 07/2015
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 09/2014
9	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 09/2005
8	AntibodiesIBA 06/2022 - 10/2010
8	Fibrinogen (Factor I)FDA Link 05/2022 - 06/2009
8	HMGB1 Protein (HMG1)IBA 01/2022 - 06/2013
8	AnticoagulantsIBA 05/2021 - 04/2009
8	SteroidsIBA 03/2021 - 02/2012
8	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2013
8	Tyrosine Kinase InhibitorsIBA 01/2021 - 11/2009
8	CholesterolIBA 01/2021 - 04/2008

Therapy/Procedure

125	Therapeutics 06/2022 - 08/2003
47	Drug Therapy (Chemotherapy) 04/2022 - 08/2003
20	Immunotherapy 12/2022 - 01/2015
17	Radiotherapy 09/2021 - 01/2014
17	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2021 - 05/2009